Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients

ConditionPrematurity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorAnn & Robert H Lurie Children's Hospital of Chicago

About this trial

The purpose of this study is to develop biocompatible wireless electronic devices that will allow continuous, non-invasive hemodynamic and physiology measurements in the ICU.

Eligibility criteria

Qualifiers

Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital

Under 18 years of age

Under 18 years of age

Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one time study visit

Disqualifiers

A skin abnormality that would potentially increase the risk of device

18 years of age or older

Determined by an attending physician or bedside care team to be too unstable (patient) or experiencing too much stress (family)

A skin abnormality that would potentially increase risk of device use

Trial design

Treatments tested in this trial

  • Wireless Wearable Vital Sign Monitor

Treatment groups

500 Participants
are divided into 2 treatment groups